Skip to main navigation Skip to search Skip to main content

A Randomized, Single-Blind, Placebo-Controlled, Self-Matched Pairing, Independent Evaluated Study to Evaluate the Efficacy & Safety of 0.03% RGN-137 Topical Gel in Subjects with Junctional & Dystrophic Epidermolysis Bullosa

SUNY Downstate Health Sciences University

Project: Research

Project Details

StatusFinished
Effective start/end date04/11/19 → 04/10/20

Funding

  • Lenus Therapeutics LLC: $1,000.00